Brief: LSL Pharma Group Announces The Signing Of Two Agreements To Market New Ophthalmic Products In Canada
03/04/2025 12:03
April 3 (Reuters) - LSL Pharma Group Inc LSL.V: LSL PHARMA GROUP ANNOUNCES THE SIGNING OF TWO AGREEMENTS TO MARKET NEW OPHTHALMIC PRODUCTS IN CANADA LSL PHARMA GROUP INC - SALES OF NEW PRODUCTS EXPECTED TO START Q4-2025 Source text: ID:nCNWm5Pb9a Further company coverage: LSL.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on LSL Pharma
See all newsBrief: LSL Pharma Group Announces CFO Transition
Canada's LSL Pharma Q2 revenue surges on acquisition boost, eye-drop launches
Brief: Lsl Pharma Group Reports Record Revenues And Second Quarter 2026 Results
Brief: LSL Pharma Group Successfully Obtained U.S. FDA Certification For The Manufacturing Of Ophthalmic Ointments For Commercialization In The United States
Brief: LSL Pharma Group Announces Closing Of The Acquisition Of Juno Otc And Final $2M Closing Of Upsized $12M Offering